Additionally, miR-20a could enhance DDP resistance of OVCAR3 ovarian cancer cells by altering the expression of EMT markers (E-cadherin, N-cadherin, and vimentin) (Liu et al., 2017). Here, CDH1 is linked to ovarian carcinoma.